More early data revealed from landmark CRISPR gene editing human trial
Vertex and CRISPR Therapeutics have presented new data from one of the first trials testing gene-editing therapy in human subjects. Fifteen months on from the first patient treatment, the highly experimental therapy is showing remarkable efficacy treat… Continue reading More early data revealed from landmark CRISPR gene editing human trial